![Graciëlle Anna Maria Beijerbacht-Schutjens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Graciëlle Anna Maria Beijerbacht-Schutjens
Director/Board Member at G. A. M. Schutjens Holding BV
Profile
Graciëlle Anna Maria Beijerbacht-Schutjens is currently a Director at Venn Life Sciences BV and G.
A.
M.
Schutjens Holding BV.
She is also a Vice President-Governance & Client Services at Venn Life Sciences Ltd.
since 2010.
Previously, she worked as the Chief Operating Officer & Executive Director at Venn Life Sciences Holdings Plc from 2015 to 2017.
Graciëlle Anna Maria Beijerbacht-Schutjens active positions
Companies | Position | Start |
---|---|---|
Venn Life Sciences Ltd.
![]() Venn Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services Venn Life Sciences Ltd. provides clinical research services. It offers drug development planning and strategy, early drug development, clinical trials, and support services. The company was founded in 2007 and is headquartered in County Dublin, Ireland. | Corporate Officer/Principal | 2009-12-31 |
Venn Life Sciences BV
![]() Venn Life Sciences BV Miscellaneous Commercial ServicesCommercial Services Part of hVIVO PLC, Venn Life Sciences BV is a clinical research organization. The company is based in Breda, Netherlands. Venn Life Sciences was acquired by Venn Life Sciences Ltd., part of hVIVO PLC from December 06, 2012 on March 25, 2010. | Director/Board Member | - |
G. A. M. Schutjens Holding BV | Director/Board Member | - |
Former positions of Graciëlle Anna Maria Beijerbacht-Schutjens
Companies | Position | End |
---|---|---|
Venn Life Sciences Holdings Plc
![]() Venn Life Sciences Holdings Plc Services to the Health IndustryHealth Services Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company was founded on February 2, 2011 and is headquartered in Dublin, Ireland. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
Venn Life Sciences Ltd.
![]() Venn Life Sciences Ltd. Miscellaneous Commercial ServicesCommercial Services Venn Life Sciences Ltd. provides clinical research services. It offers drug development planning and strategy, early drug development, clinical trials, and support services. The company was founded in 2007 and is headquartered in County Dublin, Ireland. | Commercial Services |
Venn Life Sciences Holdings Plc
![]() Venn Life Sciences Holdings Plc Services to the Health IndustryHealth Services Venn Life Sciences Holdings Plc is a clinical research organization, which provides a suite of consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. Its services include drug development planning and strategy, early drug development, clinical monitoring, medical monitoring, investigator initiated studies, clinical feasibility assessment, regulatory affairs and consulting, quality assurance, and drug development training and courses. The company was founded on February 2, 2011 and is headquartered in Dublin, Ireland. | Health Services |
Venn Life Sciences BV
![]() Venn Life Sciences BV Miscellaneous Commercial ServicesCommercial Services Part of hVIVO PLC, Venn Life Sciences BV is a clinical research organization. The company is based in Breda, Netherlands. Venn Life Sciences was acquired by Venn Life Sciences Ltd., part of hVIVO PLC from December 06, 2012 on March 25, 2010. | Commercial Services |
G. A. M. Schutjens Holding BV |
- Stock Market
- Insiders
- Graciëlle Anna Maria Beijerbacht-Schutjens